MDCX Dividends | Yield & Payout
Dividend history and payout analysis for MDCX (MDCX). Use the fiscal-year summary and the payout history table below to track dividend per share, dividend yield, and payout ratio changes over time, plus the key dates investors watch for dividend investing.
Dividend Performance Chart
Related peers
Compare More →| A Agilent Technologies, Inc. | $119.77 -0.51% |
| ALGS Aligos Therapeutics, Inc. | $7.42 -15.10% |
| COEP Coeptis Therapeutics, Inc. | $12.99 +4.42% |
| KPTI Karyopharm Therapeutics Inc. | $8.56 +1.30% |
| IPSC Century Therapeutics, Inc. | $2.59 +9.28% |
| INMB INmune Bio, Inc. | $1.32 +4.76% |
| Peer | Price | Change | Market Cap | PE | EPS | Div Yield (TTM) | Analyst Rating | Volume |
|---|---|---|---|---|---|---|---|---|
| A Agilent Technologies, Inc. | $119.77 | -0.51% | 33.88 B | 26.44 | 4.53 | 0.84% | Buy | 1.96 |
| ALGS Aligos Therapeutics, Inc. | $7.42 | -15.10% | 45.91 M | -3.03 | -2.45 | 0.00% | Buy | 181 |
| COEP Coeptis Therapeutics, Inc. | $12.99 | +4.42% | 45.64 M | -4.62 | -2.81 | 0.00% | Hold | 19 |
| KPTI Karyopharm Therapeutics Inc. | $8.56 | +1.30% | 73.08 M | -0.48 | -17.93 | 0.00% | Buy | 347 |
| IPSC Century Therapeutics, Inc. | $2.59 | +9.28% | 224.21 M | -18.50 | -0.14 | 0.00% | Buy | 1.59 |
| INMB INmune Bio, Inc. | $1.32 | +4.76% | 35.09 M | -0.71 | -1.86 | 0.00% | Hold | 305 |
Frequently Asked Questions
What is MDCX's current dividend yield and payout ratio?
The dividend yield shows how much MDCX returns to shareholders relative to its stock price, while the payout ratio indicates how much of its earnings are distributed. Monitoring these metrics helps investors evaluate whether the dividend is sustainable and supported by earnings or cash flow.
How has MDCX's dividend changed over the last 5 years?
By reviewing the historical dividend payouts for MDCX, investors can identify trends in growth or cuts. Consistent or rising dividends over time often signal financial stability, while decreasing dividends may indicate potential risks or shifts in business strategy. Use the FY summary and payout history tables to track changes across multiple years.
Is MDCX a high-yield stock compared to its industry peers?
Comparing MDCX's dividend yield with similar companies in the same sector helps gauge relative attractiveness. A higher yield can be appealing for income-focused investors, but it's important to assess sustainability alongside profitability and balance-sheet strength. Use the related peers section to benchmark dividend yield and payout characteristics.
Can MDCX maintain its dividend during market downturns?
Analyzing MDCX's liquidity, cash flow, and debt levels provides insight into whether it can sustain dividend payments during economic volatility. Stocks with strong financial health are more likely to maintain consistent dividends even when markets fluctuate. Pair dividend metrics with the FY payout ratio and the multi-year history tables for context.
Should I consider MDCX dividends as part of my long-term investment strategy?
Investors often include MDCX dividends in a long-term portfolio to generate passive income. Assessing dividend yield, payout ratio, growth history, and financial stability helps determine whether the company fits an income-focused or total-return investment strategy. Review the dividend summary and payout history tables to validate consistency over time.